Insider Selling: Dave Teitel Sells 10,000 Shares of Alere Stock (ALR)
Alere (NYSE:ALR) CFO Dave Teitel sold 10,000 shares of the company’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $35.07, for a total value of $350,700.00. Following the sale, the chief financial officer now directly owns 5,002 shares of the company’s stock, valued at approximately $175,420. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Jefferies Group cut their price target on shares of Alere from $45.00 to $40.00 in a research note on Tuesday, August 5th. They now have a “buy” rating on the stock. Separately, analysts at Leerink Swann cut their price target on shares of Alere from $40.00 to $38.00 in a research note on Tuesday, August 5th. They now have a “market perform” rating on the stock. Finally, analysts at Canaccord Genuity cut their price target on shares of Alere from $50.00 to $45.00 in a research note on Tuesday, August 5th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $42.60.
Shares of Alere (NYSE:ALR) traded up 0.29% on Monday, hitting $34.82. 368,075 shares of the company’s stock traded hands. Alere has a 1-year low of $30.14 and a 1-year high of $40.80. The stock’s 50-day moving average is $37.64 and its 200-day moving average is $36.23. The company’s market cap is $2.893 billion.
Alere (NYSE:ALR) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.42 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.58 by $0.16. The company had revenue of $738.30 million for the quarter, compared to the consensus estimate of $747.55 million. During the same quarter in the prior year, the company posted $0.64 earnings per share. The company’s quarterly revenue was down 3.4% on a year-over-year basis. Analysts expect that Alere will post $2.23 EPS for the current fiscal year.
Alere Inc is a provider of point-of-care diagnostics and services. The Company’s products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease.
Receive News & Ratings for Alere Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alere Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.